| Literature DB >> 29097393 |
Yunfei Qin1,2, Zexiong Su1, Yaoxing Wu1, Chenglei Wu1, Shouheng Jin1, Weihong Xie1, Wei Jiang3, Rongbin Zhou3, Jun Cui4.
Abstract
MAVS signalosome plays an important role in RIG-I-like receptor (RLR)-induced antiviral signaling. Upon the recognition of viral RNAs, RLRs activate MAVS, which further recruits TRAF6 and other signaling proteins to initiate type I interferon (IFN) activation. MAVS signalosome also regulates virus-induced apoptosis to limit viral replication. However, the mechanisms that control the activity of MAVS signalosome are still poorly defined. Here, we report NLRP11, a Nod-like receptor, is induced by type I IFN and translocates to mitochondria to interact with MAVS upon viral infection. Using MAVS as a platform, NLRP11 degrades TRAF6 to attenuate the production of type I IFNs as well as virus-induced apoptosis. Our findings reveal the regulatory role of NLRP11 in antiviral immunity by disrupting MAVS signalosome.Entities:
Keywords: zzm321990MAVSzzm321990; NLRP11; TRAF6; apoptosis; type I IFNs
Mesh:
Substances:
Year: 2017 PMID: 29097393 PMCID: PMC5709773 DOI: 10.15252/embr.201744480
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807